Chen, Xiaoling,Lan, Ruoxi,Jorand-Lebrun, Catherine,Yu, Henry,Goutopoulos, Andreas
申请号：
AU2016215184
公开号：
AU2016215184A1
申请日:
2016.02.05
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
The present invention relates to compounds of Formula (I) and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors. Ring A is a 5-6 membered monocyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur； which is optionally substituted.
